Ultimately, harnessing the multifaceted regulatory potential of Nrf2 offers a promising avenue to address the mechanistic complexity of ALS and pave the way for more effective, precision-guided neuroprotective therapies. The gene discussed is NFE2L2; the disease is amyotrophic lateral sclerosis.